Evidence map›Paper›PMID 25299654›Full record

ArticlePLoS neglected tropical diseases2014

Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances.

Cornelia A M van de Weg, Ralph M H G Huits, Cláudio S Pannuti, Rosalba M Brouns, Riemsdijk W A van den Berg, Henk-Jan van den Ham, Byron E E Martina, Albert D M E Osterhaus, Mihai G Netea, Joost C M Meijers and 2 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05611710 (Anakinra for Dengue Patients With Hyperinflammation - a Randomized Double-blind Placebo-controlled Trial), which is not on this map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05611710 phase2active not recruitingnot on this mapstarted 2023, after this paper: background citation

Anakinra for Dengue Patients With Hyperinflammation - a Randomized Double-blind Placebo-controlled Trial

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2023 to 2027Enrolled160ConditionsDengue, Dengue With Warning Signs, Severe Dengue, AnakinraArmsPlacebo, Anakinra
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Cytokine Storm Syndrome Associated with Hemorrhagic Fever and Other Viruses.Advances in experimental medicine and biology · 2024
    Review
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. [Correlation analysis between serum ferritin level and liver damage in acute stage of dengue fever].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Cornelia A M van de WegDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Ralph M H G HuitsEmergency Department and Department of Internal Medicine, Dr. Horacio E. Oduber Hospitaal, Oranjestad, Aruba.
Cláudio S PannutiInstituto de Medicina Tropical de São Paulo e Departamento de Moléstias Infecciosas e Parasitárias (LIM-52), Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Rosalba M BrounsLandslaboratorium, Oranjestad, Aruba.
Riemsdijk W A van den BergLandslaboratorium, Oranjestad, Aruba.
Henk-Jan van den HamDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Byron E E MartinaDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Albert D M E OsterhausDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Mihai G NeteaDepartment of Experimental Internal Medicine, Radboud University, Nijmegen, The Netherlands.
Joost C M MeijersDepartment of Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Eric C M van GorpDepartment of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Esper G KallasDisciplina de Imunologia Clínica e Alergia (LIM-60), Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Erasmus MC · NLUniversity of Aruba · AWUniversidade de São Paulo · BRAcademic Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring a dengue outbreak on the Caribbean island Aruba, highly elevated levels of ferritin were detected in dengue virus infected patients. Ferritin is an acute-phase reactant and hyperferritinaemia is a hallmark of diseases caused by extensive immune activation, such as haemophagocytic lymphohistiocytosis. The aim of this study was to investigate whether hyperferritinaemia in dengue patients was associated with clinical markers of extensive immune activation and coagulation disturbances. METHODOLOGY/PRINCIPAL

findingsLevels of ferritin, standard laboratory markers, sIL-2R, IL-18 and coagulation and fibrinolytic markers were determined in samples from patients with uncomplicated dengue in Aruba. Levels of ferritin were significantly increased in dengue patients compared to patients with other febrile illnesses. Moreover, levels of ferritin associated significantly with the occurrence of viraemia. Hyperferritinaemia was also significantly associated with thrombocytopenia, elevated liver enzymes and coagulation disturbances. The results were validated in a cohort of dengue virus infected patients in Brazil. In this cohort levels of ferritin and cytokine profiles were determined. Increased levels of ferritin in dengue virus infected patients in Brazil were associated with disease severity and a pro-inflammatory cytokine profile. CONCLUSIONS/SIGNIFICANCE: Altogether, we provide evidence that ferritin can be used as a clinical marker to discriminate between dengue and other febrile illnesses. The occurrence of hyperferritinaemia in dengue virus infected patients is indicative for highly active disease resulting in immune activation and coagulation disturbances. Therefore, we recommend that patients with hyperferritinaemia are monitored carefully.

Indexed as

AdultBiomarkersBlood Coagulation DisordersBrazilCohort StudiesCytokinesDengueDengue VirusDisease OutbreaksFemaleFerritinsHumansInterleukin-18MaleMiddle AgedNetherlandsBiomarkersCytokinesFerritinsInterleukin-18

Identifiers

PMID25299654
PMCPMC4191960
OpenAlexW1970675752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.